Please assess the completion status of the following clinical trial:

Trial Title: Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients 18-75 years of age~* Kidney transplant 30-180 days post-transplantation~* Receipt of cyclosporine or tacrolimus, CellCept, and corticosteroids for greater than 14 days prior to study entry~* No known contraindications to sirolimus~Exclusion Criteria:~* Multiple organ transplant recipients or secondary kidney transplant recipients~* Corticosteroid-resistant rejection episode within 90 days prior to study entry or corticosteroid-sensitive rejection episode within 30 days prior to study entry~* More than 1 biopsy-proven episode of acute rejection prior to study entry~* Treated with sirolimus before the study~* Organ transplant or expected organ transplant, other than kidney~* History of malignancy in the last 5 years (except successfully treated localized non-melanotic skin cancer)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).